To study the causes of sheetapitta and its treatment in purview of samshodhan and samshaman

To study the aetiopathogenesis of sheetapitta and its principle management in purview of samshodhan and samshaman chikitsa

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034846

Enrollment

Registered

2021-07-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L49-L54- Urticaria and erythema

Interventions

Intervention1: Sunthi churna Darvi ghrita Trivrit churna evum trifla kwath for internal use: 10 patients will be given sunthi churna for deepan pachan for 2-3 days followed by snehapan with darvi ghri

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients willing for trial b)Patients with classical sign and symptoms of sheetapitta- Raag(redness) -kandu(itching) -vartidansha sansthan(wheal formation)

Exclusion criteria

Exclusion criteria: a)Patients not willing for trial b)Patient whose age is below 18yrs or above 60yrs c)Pregnancy,lactation or puerperium d)Presence of local infections or skin diseases on the proposed site of allergy patch test

Design outcomes

Primary

Measure	Time frame
Overall improvement which will be shown by the patients in sign and symptoms according to subjective and objective criteria.Timepoint: 45 days	—

Secondary

Measure	Time frame
General feeling of well beingTimepoint: 45 days	—

Countries

India

Contacts

Public ContactSakshi Awasthi

RGGPG Ayurvedic College and Hospital

satishgandharve@gmail.com9418143549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026